Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial. - Wikidata - awgldk - TriplyDB

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

http://www.wikidata.org/entity/Q34569443

about

Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.Ranolazine: A Contemporary Review A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve Ranolazine in Cardiac Arrhythmia Management standards for stable coronary artery disease in India.Ranolazine recruits muscle microvasculature and enhances insulin action in rats.Resolution of angina pectoris and improvement of the coronary flow reserve after ranolazine treatment in a woman with isolated impaired coronary microcirculation.Conversion of the Seattle Angina Questionnaire into EQ-5D utilities for ischemic heart disease: a systematic review and catalog of the literature.Update on ranolazine in the management of angina.Effect of ranolazine on A1C and glucose levels in hyperglycemic patients with non-ST elevation acute coronary syndrome.Nonacute coronary syndrome anginal chest pain.Emerging clinical role of ranolazine in the management of angina.Efficacy and safety of ranolazine in patients with chronic stable angina.Ranolazine: a new approach to treating an old problem.Comparative effectiveness of Di'ao Xin Xue Kang capsule and Compound Danshen tablet in patients with symptomatic chronic stable angina.Comparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease - a randomized controlled trial.Anti-anginal and anti-ischemic effects of late sodium current inhibition Extended-release ranolazine: critical evaluation of its use in stable angina.Effect of Ranolazine Monotherapy on Glycemic Control in Subjects With Type 2 Diabetes Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study.Ranolazine for the treatment of chronic stable angina: a cost-effectiveness analysis from the UK perspective.Effect of ranolazine on left ventricular dyssynchrony in patients with coronary artery disease.Ranolazine in patients with coronary artery disease.Long term medical treatment of stable coronary disease.Utility of ranolazine in chronic stable angina patients.Ranolazine: a new option in the management of chronic stable angina.Ranolazine combined with enalapril or metoprolol prevents progressive LV dysfunction and remodeling in dogs with moderate heart failure.Reply to "Good! is it the best ???The Effects of Ranolazine on Paroxysmal Atrial Fibrillation in Patients with Coronary Artery Disease: A Preliminary Observational Study.Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.Evaluating symptoms to improve quality of life in patients with chronic stable angina.Safety and Efficacy of Ranolazine for the Treatment of Chronic Angina Pectoris.Refractory atrial fibrillation effectively treated with ranolazine.Ranolazine: an anti-anginal drug with further therapeutic potential.Impact of angina frequency on health utility values of patients with chronic stable angina Emerging medical treatment for angina pectoris.Cell therapy for heart failure: the need for a new therapeutic strategy.Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises.Stable angina pectoris: antianginal therapies and future directions.Treatment strategies for chronic stable angina.

P2860

Q24605881-F82ABAEE-5AEF-4579-B2FD-AA7532AD5FD5 Q26765421-89155C8C-3130-47C4-BF28-ACF981E026D0 Q26776330-3504FB08-C1BE-4EF3-A4AE-CBB8DFD95860 Q26784029-97487FFD-43F0-49DA-9D19-0EF160848E4F Q30239853-88CB23FF-5820-452B-888F-9C5AF5F113C6 Q30456763-F3EAE0AE-072E-40CE-9BA3-18648351A075 Q33559253-58E8481B-86B5-4816-AEBB-F22245AF4D76 Q33669496-44296B7A-A9C7-4BE8-B275-9DED3D60C6A8 Q33831222-873F01C3-F65D-4BDB-A46B-07A51875B8D2 Q33872995-E360E14F-2895-4565-9058-9E8E136F679F Q33878551-7B51B774-7002-4CC4-A042-C926A8A9F7E6 Q34235939-9854B152-9429-4B27-A792-6F13499B931E Q34383219-09A50AC2-9032-47A6-A200-234F6283EF7E Q34457675-E1178596-7E18-4E66-853E-E91A577A75C9 Q34507881-D2606E71-AA80-4EC0-8E81-09B7A838B200 Q35139678-F1A141E4-DCBD-4829-8252-EF97886292D3 Q35147202-ECB24A30-54C1-4AFE-8A17-8091E3174D4E Q35193935-71B792A8-DC0A-4030-8BA3-5021A876E3C8 Q35769527-5D8811C6-7439-4243-A461-785CDB2EBEDA Q35873307-A68D5CF6-9869-4BDA-892A-7604C643AEF3 Q36258672-C3C3552B-2DBD-430D-A311-5D37F0174F9F Q36354376-F43D8B68-EB9F-4415-83AD-01C2A53366D8 Q36916931-113E0525-9B1D-4DD9-A54C-F3B5B98AFCDC Q36969811-D445E53C-DE94-4E5F-8132-1974A609DCA0 Q37004023-755546B0-3665-49D4-BAFB-225928CDF3E2 Q37015957-7F200776-C67C-43E6-A383-2EACC6FD3FFC Q37038947-32652138-47B6-433D-9B3A-603DDC2B9112 Q37102259-424F4BD7-0DD2-4860-B18D-F783C3FD0298 Q37115123-DB1567E7-1980-4395-8A4A-DA1BF767FFCD Q37140881-33768249-E566-48CD-BD5D-81CF8185E52C Q37449790-FDF58881-BCAB-4E4A-991C-809DE29220C9 Q37599625-902CFC42-4A75-44FD-878A-E7BFDD16462D Q37624444-6640DA59-B89C-4AD6-9DE0-38782811E5F0 Q37707393-1C4B37ED-E7D2-449F-9538-54FA4047E43E Q37716587-8E1EE552-546E-4AB5-A6BD-FC1E1426A437 Q37729183-A50C15D6-DC38-4DA7-A989-20880AEF0CFC Q37776514-428C0150-882A-41C2-9F36-540F8E0C6650 Q37827882-4779B141-2C61-4E4D-ACEC-AE8F3A41AE35 Q37924086-EAEB50AE-B2A0-4C0E-8021-AAB282C02A53 Q37958035-EBC6A737-4E02-479E-9AC5-EF254BC416F1

P2860

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.

http://www.wikidata.org/entity/Q34569443

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Antianginal efficacy of ranola ...... zine in Chronic Angina) trial.

@ast

Antianginal efficacy of ranola ...... zine in Chronic Angina) trial.

@en

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA

@nl

type

label

Antianginal efficacy of ranola ...... zine in Chronic Angina) trial.

@ast

Antianginal efficacy of ranola ...... zine in Chronic Angina) trial.

@en

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA

@nl

prefLabel

Antianginal efficacy of ranola ...... zine in Chronic Angina) trial.

@ast

Antianginal efficacy of ranola ...... zine in Chronic Angina) trial.

@en

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA

@nl

P1433

Q34569443-380B65BA-351A-4DA0-A8E8-5672EEEBB809

P1476

Q34569443-34AD75E6-5605-4169-8AFD-0BF7E85DD29B

P2093

Q34569443-0A2221B9-539A-40EE-BFD8-12BA2F637520

Q34569443-3B510462-2CAE-41C2-AC1A-0DA3C5DD6EA8

Q34569443-9CD7AE94-BDF0-46A7-80D8-3698A10520EF

Q34569443-A6B25054-F9C9-49B7-B7F1-4FBFCA0DF336

Q34569443-CFDDFF2D-F812-4FD3-AC14-1632C217BA40

Q34569443-EFF9F34C-9C8E-49AB-8996-0EFBF7680D73

P304

Q34569443-03D2AC9A-4B48-4CD1-8F8D-634DAEB9CAB6

P31

Q34569443-F7DACEFC-262F-4E1B-9BCD-5FB9A28BDDAE

P356

Q34569443-5E1560DA-0D07-422E-91F1-751C4DD6C701

P407

Q34569443-0F1D2C81-9002-42C6-8686-EF101CBDEC11

P433

Q34569443-FC303534-3279-4553-A9A9-297AB50CE18F

P478

Q34569443-6B528A16-9234-4A90-A709-25548A30099F

P577

Q34569443-A8E036AD-D080-4D5B-B8A9-C35630DC88E8

P5875

Q34569443-51ADAE9A-2C62-4852-8384-3998BAA01E42

P698

Q34569443-D5881D44-5A68-4132-A81C-9D4A3A8A17AD

P356

J.JACC.2006.05.044

P1433

Journal of the American College of Cardiology

P1476

Antianginal efficacy of ranola ...... zine in Chronic Angina) trial.

@en

P2093

Alexey Blokhin

http://www.w3.org/2001/XMLSchema#string

ERICA Investigators

http://www.w3.org/2001/XMLSchema#string

I-Zu Huang

http://www.w3.org/2001/XMLSchema#string

Lixin Meng

http://www.w3.org/2001/XMLSchema#string

Nikolay A Gratsiansky

http://www.w3.org/2001/XMLSchema#string

Peter H Stone

http://www.w3.org/2001/XMLSchema#string

P304

566-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JACC.2006.05.044

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2006-06-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6910543

http://www.w3.org/2001/XMLSchema#string

P698

16875985

http://www.w3.org/2001/XMLSchema#string